<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35190258</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1437-7780</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</Title>
          <ISOAbbreviation>J Infect Chemother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings.</ArticleTitle>
        <Pagination>
          <StartPage>718</StartPage>
          <EndPage>721</EndPage>
          <MedlinePgn>718-721</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiac.2022.02.005</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1341-321X(22)00045-9</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The Japanese Respiratory Society (JRS) scoring system is a useful tool for identifying Mycoplasma pneumoniae pneumonia. Most COVID-19 pneumonia in non-elderly patients (aged &lt;60 years) are classified as atypical pneumonia using the JRS scoring system. We evaluated whether physicians could distinguish between COVID-19 pneumonia and M. pneumoniae pneumonia using chest computed tomography (CT) findings. In addition, we investigated chest CT findings if there is a difference between the variant and non-variant strain.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This study was conducted at five institutions and assessed a total of 823 patients with COVID-19 pneumonia (335 had lineage B.1.1.7.) and 100 patients with M. pneumoniae pneumonia.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In COVID-19 pneumonia, at the first CT examination, peripheral, bilateral ground-glass opacity (GGO) with or without consolidation or crazy-paving pattern was observed frequently. GGO frequently had a round morphology (39.2%). No differences were observed in the radiological findings between the non-B.1.1.7 groups and B.1.1.7 groups. The frequency of pleural effusion, lymphadenopathy, bronchial wall thickening and nodules (tree-in-bud and centrilobular) was low. In contrast to COVID-19 pneumonia, bronchial wall thickening (84%) was observed most frequently, followed by nodules (81%) in M. pneumoniae pneumonia. These findings were significantly higher in M. pneumoniae pneumonia than COVID-19 pneumonia.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results demonstrated that a combination of the JRS scoring system and chest CT findings is useful for the rapid presumptive diagnosis of COVID-19 pneumonia in patients aged &lt;60 years. However, this clinical and radiographic diagnosis is not adapted to elderly people.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Miyashita</LastName>
            <ForeName>Naoyuki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan. Electronic address: miyashin@hirakata.kmu.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakamori</LastName>
            <ForeName>Yasushi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Kansai Medical University Medical Center, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogata</LastName>
            <ForeName>Makoto</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fukuda</LastName>
            <ForeName>Naoki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamura</LastName>
            <ForeName>Akihisa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishiura</LastName>
            <ForeName>Yoshihisa</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Division of Respiratory Medicine, Oncology and Allergology, Kansai Medical University Medical Center, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nomura</LastName>
            <ForeName>Shosaku</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Infect Chemother</MedlineTA>
        <NlmUniqueID>9608375</NlmUniqueID>
        <ISSNLinking>1341-321X</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Chest computed tomography</Keyword>
        <Keyword MajorTopicYN="N">Community-acquired pneumonia</Keyword>
        <Keyword MajorTopicYN="N">JRS scoring System</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>46</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35190258</ArticleId>
        <ArticleId IdType="pmc">PMC8828417</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jiac.2022.02.005</ArticleId>
        <ArticleId IdType="pii">S1341-321X(22)00045-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Cevik M., Kuppalli K., Kindrachuk J., Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33097561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Committee for the Japanese Respiratory Society guidelines for the management of respiratory infections. Guidelines for the management of community acquired pneumonia in adults, revised edition. Respirology. 2006;11(Suppl 3):S79âS133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16913899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, et al. Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines. Respirology (in press).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8661815</ArticleId>
            <ArticleId IdType="pubmed">34755416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito S., Ishida T., Togashi K., Niimi A., Koyama H., Ishimori T., et al.  Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography. Eur J Radiol. 2009;72:388â395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7127011</ArticleId>
            <ArticleId IdType="pubmed">18835120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W., Xu Y., Gao R., Lu R., Han K., Wu G., et al.  Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843â1844.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7066521</ArticleId>
            <ArticleId IdType="pubmed">32159775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song F., Shi N., Shan F., Zhang Z., Shen J., Lu H., et al.  Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295:210â217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7233366</ArticleId>
            <ArticleId IdType="pubmed">32027573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao W., Zhong Z., Xie X., Yu Q., Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. Am Journal Rev. 2020;214:1072â1077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32125873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernheim A., Mei X., Huang M., Yang Y., Fayad Z.A., Zhang N., et al.  Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295:685â691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7233369</ArticleId>
            <ArticleId IdType="pubmed">32077789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan F., Ye T., Sun P., Gui S., Liang B., Li L., et al.  Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. 2020;295:715â721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7233367</ArticleId>
            <ArticleId IdType="pubmed">32053470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai H.X., Hsieh B., Xiong Z., Halsey K., Choi J.W., Tran T.M.L., et al.  Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;296:E46âE54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7233414</ArticleId>
            <ArticleId IdType="pubmed">32155105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francone M., Iafrate F., Masci G.M., Coco S., Cilia F., Manganaro F., et al.  Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30:6808â6817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7334627</ArticleId>
            <ArticleId IdType="pubmed">32623505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams H.J.A., Kwee T.C., Yakar D., Hope M.D., Kwee R.M. Chest CT imaging signature of coronavirus disease 2019 infection: in pursuit of the scientific evidence. Chest. 2020;158:1885â1895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7314684</ArticleId>
            <ArticleId IdType="pubmed">32592709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Dong C., Hu Y., Li C., Ren Q., Zhang X., et al.  Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;296:E55âE64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7233482</ArticleId>
            <ArticleId IdType="pubmed">32191587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425â434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7159053</ArticleId>
            <ArticleId IdType="pubmed">32105637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W., et al.  Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296:E32âE40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7233399</ArticleId>
            <ArticleId IdType="pubmed">32101510</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
